Botulinum toxin A: new hope for RLS?
Kushida
Clete A
CA
Stanford University Center of Excellence for Sleep Disorders, 401 Quarry Road, Suite 3301, Stanford, CA 94305-5730, USA. clete@stanford.edu
D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D006801:Humans; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D012148:Restless Legs Syndrome / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A